Healthcare provider profile · identity verified

David B. Levy, MD

Family Practice · CHICAGO, IL · NPI 1437101714

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	830	262
Amlodipine Besylate	Amlodipine Besylate	442	136
Lisinopril	Lisinopril	405	123
Rosuvastatin Calcium	Rosuvastatin Calcium	388	115
Levothyroxine Sodium	Levothyroxine Sodium	370	106
Metoprolol Succinate	Metoprolol Succinate	320	106
Metformin Hcl	Metformin Hcl	319	104
Olmesartan Medoxomil	Olmesartan Medoxomil	313	85
Pantoprazole Sodium	Pantoprazole Sodium	289	87
Losartan Potassium	Losartan Potassium	259	82
Gabapentin	Gabapentin	250	61
Alprazolam	Alprazolam	247	48
Tamsulosin Hcl	Tamsulosin Hcl	245	79
Furosemide	Furosemide	219	64
Glimepiride	Glimepiride	212	59
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	190	52
Jardiance	Empagliflozin	182	41
Trazodone Hcl	Trazodone Hcl	180	51
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	176	54
Albuterol Sulfate Hfa	Albuterol Sulfate	152	54
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	149	32
Eliquis	Apixaban	146	39
Omeprazole	Omeprazole	146	49
Torsemide	Torsemide	137	47
Meloxicam	Meloxicam	136	40
Simvastatin	Simvastatin	132	41
Tramadol Hcl	Tramadol Hcl	130	33
Ozempic	Semaglutide	127	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	36
Clopidogrel	Clopidogrel Bisulfate	122	36
Prednisone	Prednisone	119	46
Carvedilol	Carvedilol	118	41
Alendronate Sodium	Alendronate Sodium	117	31
Metoprolol Tartrate	Metoprolol Tartrate	113	34
Spironolactone	Spironolactone	99	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	32
Pravastatin Sodium	Pravastatin Sodium	92	27
Metformin Hcl Er	Metformin Hcl	88	30
Hydrochlorothiazide	Hydrochlorothiazide	80	26
Esomeprazole Magnesium	Esomeprazole Magnesium	77	20
Valsartan	Valsartan	74	24
Synjardy Xr	Empagliflozin/Metformin Hcl	70	16
Finasteride	Finasteride	67	25
Allopurinol	Allopurinol	66	16
Glipizide	Glipizide	65	23
Propranolol Hcl	Propranolol Hcl	56	13
Warfarin Sodium	Warfarin Sodium	52	13
Enalapril Maleate	Enalapril Maleate	51	18
Sertraline Hcl	Sertraline Hcl	49	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	16
Amitriptyline Hcl	Amitriptyline Hcl	47	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Ezetimibe	Ezetimibe	46	suppressed
Mirtazapine	Mirtazapine	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	20
Lorazepam	Lorazepam	44	suppressed
Azithromycin	Azithromycin	43	35
Celecoxib	Celecoxib	43	13
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Mounjaro	Tirzepatide	43	suppressed
Donepezil Hcl	Donepezil Hcl	42	11
Atenolol	Atenolol	41	suppressed
Entresto	Sacubitril/Valsartan	41	11
Farxiga	Dapagliflozin Propanediol	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	16
Pregabalin	Pregabalin	40	14
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Glipizide Er	Glipizide	38	suppressed
Lansoprazole	Lansoprazole	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	12
Xarelto	Rivaroxaban	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	33	suppressed
Synjardy	Empagliflozin/Metformin Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	12
Clonazepam	Clonazepam	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	13
Memantine Hcl	Memantine Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Ibuprofen	Ibuprofen	29	16
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	14
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Cephalexin	Cephalexin	25	19
Famotidine	Famotidine	25	11
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	17
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Colchicine	Colchicine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Dilt-Xr	Diltiazem Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Fenofibrate	Fenofibrate	17	suppressed
Nystatin	Nystatin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Lidocaine	Lidocaine	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clozapine	Clozapine	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Diazepam	Diazepam	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Linzess	Linaclotide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error